Milana Arantza B. S.
- Country
- Spain
- Department
- 03407: Oncología Médica
Research Overview
- Comparative Evaluation of Giredestrant and Triptorelin Versus Anastrozole and Triptorelin in Premenopausal ER-Positive/HER2-Negative Early Breast Cancer
- Evaluation of Samuraciclib and Elacestrant Combination in Metastatic or Locally Advanced HR+ HER2- Breast Cancer
- Phase II Randomized Trial of Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in PD-L1-Negative Metastatic Triple-Negative Breast Cancer
Data & Insights
Has run more than one trial at 39 of 191 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, exploring innovative therapeutic combinations for advanced disease management.
- Hormone-dependent breast cancer treatment
- Advanced therapeutic combinations
- Targeted therapy approaches
Their clinical expertise extends to evaluating novel treatment combinations, particularly focusing on endocrine therapy resistance in breast cancer.
Therapeutic Development
The investigator focuses on developing and evaluating combination therapies for breast cancer treatment, with particular attention to drug interactions and optimal dosing strategies.
- Novel drug combinations
- Dose optimization studies
- Treatment efficacy assessment
Their work encompasses determining effective dosing regimens and evaluating therapeutic responses in clinical settings.
Clinical Outcomes
The investigator specializes in assessing progression-free survival and treatment effectiveness in advanced breast cancer patients, particularly focusing on novel therapeutic approaches.
- Treatment response evaluation
- Disease progression monitoring
- Long-term outcome assessment
Their research emphasizes measuring clinical benefits and treatment outcomes in breast cancer therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.